Ascendis Pharma A/S (NASDAQ:ASND) reported 6/30/2017 earnings this Afternoon, coming in at ($1.10) per share, missing Wall Street’s estimates of ($0.80) per Share. Revenue for the quarter came in at $0.44 million missing the streets estimates of $0.78 million
Analyst Coverage For Ascendis Pharma A/S (NASDAQ:ASND)
These are 1 Hold Rating, 3 Buy Ratings .
The current consensus rating for Ascendis Pharma A/S (NASDAQ:ASND) is Buy (Score: 2.75) with a consensus target price of $31.00 , a potential (10.71% upside)
Recent Trading for Ascendis Pharma A/S (NASDAQ:ASND) Shares of Ascendis Pharma A/S closed the previous trading session at 28.00 0.00 0.00% with 104,846 shares trading hands.